Global Fund head repeats appeal for emerging countries to invest more in fight against AIDS, TB, malaria

NewsGuard 100/100 Score

Global Fund to Fight AIDS, Tuberculosis and Malaria Director Michel Kazatchkine on Thursday repeated his appeal for emerging countries to scale up their contributions to fight the three major diseases, Agence France-Presse reports.

"As we moved from G8 to G20 in global governance shouldn't emerging countries also participate in global solidarity?" Kazatchkine asked, noting that G8 countries currently contribute 85 percent of the donations to the Global Fund, according to the news service. "While acknowledging that 'China, Brazil and India should remain net beneficiaries the Global Fund,' Kazatchkine said that 'at the same time, they have to be contributors,'" the AFP writes.

Kazatchkine has been meeting with representatives from emerging countries, such as Brazil, China and India to discuss the prospects their help in closing the funds' funding gap (9/16).

Kazatchkine's efforts come ahead of the Global Fund "replenishment conference" next month, where the group will decide on its financing for its programs over the next three years, VOA News reports, in an article that examines the impact the fund has had since its creation in 2000, as described by Kazatchkine (Schlein, 9/16).

"Overall, the fund needs 17 billion dollars (12.9 billion euros) in the next three years in order to meet U.N. targets on cutting the occurrences of these diseases," the AFP adds (9/16).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows